oxazoles has been researched along with Melanoma in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, S; Pan, J; Ye, Q; Zhang, J | 1 |
| Ameratunga, M; Aspegren, J; Bono, P; Braña, I; de Bono, JS; Korjamo, T; Plummer, R; Postel-Vinay, S; Snapir, A | 1 |
| Ohshima, Y; Suzuki-Karasaki, M; Suzuki-Karasaki, Y; Takata, N; Tokuhashi, Y; Yoshida, Y | 1 |
| Aplin, AE; Chervoneva, I; Erkes, DA; Nikbakht, N; Tiago, M | 1 |
| Aplin, AE; Berger, AC; Capparelli, C; Chervoneva, I; Erkes, DA; Field, CO; Hartsough, EJ; Purwin, TJ; Tiago, M; Villanueva, J | 1 |
| He, Z; Jordan, R; Kabanov, AV; Luxenhofer, R; Miao, L; S-Manickam, D | 1 |
| Buijsman, RC; de Man, J; de Roos, JA; de Vetter, JR; Prinsen, MB; Spijkers-Hagelstein, JA; Uitdehaag, JC; van Doornmalen, AM; Zaman, GJ | 1 |
| Chen, BM; Cheng, CM; Cheng, TL; Liao, KW; Roffler, SR; Tzou, SC | 1 |
| Al-Abed, Y; Bevelacqua, Y; Cardile, V; Cheng, KF; Dabideen, D; Donia, M; Garotta, G; Harhaji, L; Libra, M; Maksimovic-Ivanic, D; Malaponte, G; Mijatovic, S; Miljkovic, D; Mojic, M; Nicoletti, F; Stosic-Grujicic, S | 1 |
| Carl, PL; Chakravarty, PK; Katzenellenbogen, JA; Weber, MJ | 1 |
| Crews, P; Nieto, RM; Rodríguez, J | 1 |
| Ahn, BZ; Hong, DH; Kim, HM; Kim, Y; Nam, NH; You, YJ | 1 |
| Hemsworth, GR; Jensen, KE; Kraska, AR; Wolff, JS | 1 |
1 trial(s) available for oxazoles and Melanoma
| Article | Year |
|---|---|
First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents; Biological Availability; Blood Platelets; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Fatigue; Female; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Maximum Tolerated Dose; Melanoma; Middle Aged; Neoplasms; Ovarian Neoplasms; Oxazoles; Prostatic Neoplasms, Castration-Resistant; Proteins; Pyridines; Quinolines; Sarcoma; Small Cell Lung Carcinoma; Young Adult | 2020 |
12 other study(ies) available for oxazoles and Melanoma
| Article | Year |
|---|---|
Transcriptional inhibition by CDK7/9 inhibitor SNS-032 abrogates oncogene addiction and reduces liver metastasis in uveal melanoma.
Topics: Animals; Apoptosis; Biomarkers, Tumor; Cell Cycle Proteins; Cell Line, Tumor; Cyclin-Dependent Kinase 9; Cyclin-Dependent Kinase-Activating Kinase; Cyclin-Dependent Kinases; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Humans; Kruppel-Like Factor 4; Liver Neoplasms; Male; Melanoma; Mice; Oncogene Addiction; Oxazoles; Signal Transduction; Thiazoles; Transcription Factors; Uveal Neoplasms; Xenograft Model Antitumor Assays | 2019 |
Mitochondrial Ca2+ removal amplifies TRAIL cytotoxicity toward apoptosis-resistant tumor cells via promotion of multiple cell death modalities.
Topics: Acrylamides; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzoates; Biological Transport; Bone Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Calcium; Cell Membrane Permeability; Cell Proliferation; Drug Resistance, Neoplasm; Humans; Melanoma; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Osteosarcoma; Oxazoles; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured | 2017 |
BET Inhibition Modifies Melanoma Infiltrating T Cells and Enhances Response to PD-L1 Blockade.
Topics: Animals; Antineoplastic Agents, Immunological; CD8-Positive T-Lymphocytes; Cell Growth Processes; Cell Line, Tumor; Disease Models, Animal; Drug Synergism; Forkhead Transcription Factors; Humans; Immunotherapy; Lymphocytes, Tumor-Infiltrating; Melanoma; Mice; Nerve Tissue Proteins; Oxazoles; Programmed Cell Death 1 Receptor; Pyridines; Pyrroles; Receptors, Cell Surface; Skin Neoplasms; T-Lymphocytes, Regulatory; Tumor Burden | 2019 |
The next-generation BET inhibitor, PLX51107, delays melanoma growth in a CD8-mediated manner.
Topics: Animals; Antineoplastic Agents; Apoptosis; CD8-Positive T-Lymphocytes; Cell Proliferation; Humans; Male; Melanoma; Mice; Mice, Inbred C57BL; Oxazoles; Proteins; Pyridines; Pyrroles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2019 |
A Low Protein Binding Cationic Poly(2-oxazoline) as Non-Viral Vector.
Topics: Animals; Gene Transfer Techniques; Melanoma; Mice; Oxazoles; Plasmids; Poloxalene; Protein Binding; Transfection; Tumor Cells, Cultured | 2015 |
Selective Targeting of CTNBB1-, KRAS- or MYC-Driven Cell Growth by Combinations of Existing Drugs.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aza Compounds; Benzimidazoles; beta Catenin; Cell Line, Tumor; Cell Proliferation; Humans; Imidazoles; Indazoles; Indoles; Melanoma; Molecular Targeted Therapy; Mutation; Oxazoles; Oximes; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins p21(ras); Pyridones; Pyrimidinones; Quinolines; Sulfonamides; Triazoles; Vemurafenib | 2015 |
Hapten-directed targeting to single-chain antibody receptors.
Topics: Aniline Mustard; Animals; Antibodies, Monoclonal; Cell Line, Tumor; Drug Delivery Systems; Gene Expression; Haptens; Immunotherapy; Injections, Intravenous; Melanoma; Mice; Neoplasms, Experimental; Oxazoles; Polyethylene Glycols; Prodrugs; Receptors, Cell Surface; Recombinant Proteins | 2004 |
Novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide (GIT-27NO) induces p53 mediated apoptosis in human A375 melanoma cells.
Topics: Acetates; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Humans; Melanoma; Nitric Oxide Donors; Oxazoles; Tumor Suppressor Protein p53; YY1 Transcription Factor | 2008 |
Plasmin-activated prodrugs for cancer chemotherapy. 1. Synthesis and biological activity of peptidylacivicin and peptidylphenylenediamine mustard.
Topics: Animals; Antineoplastic Agents; Biotransformation; Cell Survival; Cell Transformation, Neoplastic; Female; Fibrinolysin; Isoxazoles; Melanoma; Mice; Nitrogen Mustard Compounds; Oligopeptides; Ovarian Neoplasms; Oxazoles; Plasminogen Activators | 1983 |
New structures and bioactivity patterns of bengazole alkaloids from a choristid marine sponge.
Topics: Alkaloids; Animals; Antineoplastic Agents; Colonic Neoplasms; Drug Screening Assays, Antitumor; Humans; Hydrolysis; Melanoma; Oxazoles; Porifera; Tumor Cells, Cultured | 1993 |
Combretoxazolones: synthesis, cytotoxicity and antitumor activity.
Topics: Animals; Antineoplastic Agents; Biochemistry; Drug Design; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Melanoma; Mice; Mice, Inbred Strains; Oxazoles; Tumor Cells, Cultured | 2001 |
Delayed cutaneous hypersensitivity to oxazolone in mice with tumors.
Topics: Animals; Carmustine; Doxorubicin; Female; Hypersensitivity, Delayed; Leukemia, Experimental; Leukemia, Lymphoid; Melanoma; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Oxazoles; Oxazolone; Sarcoma 180; Skin | 1978 |